Pharmaceutical

Modella AI and AstraZeneca link for cancer clinical development

Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.

Jul 5, 2025 - 06:00
Modella AI and AstraZeneca link for cancer clinical development
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
Read the original article

Tags:

Previous Article

Five lessons from biopharma companies’ data transformation journeys

Next Article

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves Astellas’ VYLOY for gastric cancer treatment

FDA approves Astellas’ VYLOY for gastric cancer treatment

Oct 22, 2024

Simtra BioPharma to invest more than $250m in US facility

Simtra BioPharma to invest more than $250m in US facility

Mar 1, 2024

JAMA’s new editor settles in, bringing open access and other changes

JAMA’s new editor settles in, bringing open access and ...

Mar 19, 2023